Literature DB >> 16892084

Mitochondria and cancer: is there a morphological connection?

E Alirol1, J C Martinou.   

Abstract

Mitochondria are key players in several cellular functions including growth, division, energy metabolism, and apoptosis. The mitochondrial network undergoes constant remodelling and these morphological changes are of direct relevance for the role of this organelle in cell physiology. Mitochondrial dysfunction contributes to a number of human disorders and may aid cancer progression. Here, we summarize the recent contributions made in the field of mitochondrial dynamics and discuss their impact on our understanding of cell function and tumorigenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16892084     DOI: 10.1038/sj.onc.1209600

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

Review 1.  Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion.

Authors:  M Cecilia Caino; Dario C Altieri
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.

Authors:  Alessandro Giamboi Miraglia; Sara Travaglione; Stefania Meschini; Loredana Falzano; Paola Matarrese; Maria Giovanna Quaranta; Marina Viora; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

3.  Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells.

Authors:  Santanu Dasgupta; Mohammad Obaidul Hoque; Sunil Upadhyay; David Sidransky
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

Review 4.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

Review 5.  Melatonin, mitochondria, and the cancer cell.

Authors:  Sara Proietti; Alessandra Cucina; Mirko Minini; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

6.  Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism.

Authors:  Helene Pelicano; Weiqin Lu; Yan Zhou; Wan Zhang; Zhao Chen; Yumin Hu; Peng Huang
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.

Authors:  Vaikunth Cuchelkar; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-09-04       Impact factor: 4.939

8.  Mitochondrial structural alterations in ovarian cancer patient-derived xenografts resistant to cisplatin.

Authors:  Francesca Ricci; Alessandro Corbelli; Roberta Affatato; Rosaria Chilà; Michela Chiappa; Laura Brunelli; Robert Fruscio; Roberta Pastorelli; Fabio Fiordaliso; Giovanna Damia
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

9.  Disabling mitochondrial reprogramming in cancer.

Authors:  M Cecilia Caino; Dario C Altieri
Journal:  Pharmacol Res       Date:  2015-09-10       Impact factor: 7.658

10.  An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.

Authors:  Seung Hun Jeong; In Sung Song; Hyoung Kyu Kim; Sung Ryul Lee; Suhee Song; Hongsuk Suh; Young Geol Yoon; Young Hyun Yoo; Nari Kim; Byoung Doo Rhee; Kyung Soo Ko; Jin Han
Journal:  Mol Cells       Date:  2012-10-18       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.